Announcements
- 2025.08.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
- 2025.07.21 VOLUNTARY ANNOUNCEMENT - THE SUCCESSFUL COMPLETION OF KEN-VALVE'S FIRST BATCH OF COMMERCIAL IMPLANTATIONS
- 2025.07.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
- 2025.06.27 VOLUNTARY ANNOUNCEMENT THE 30-DAY CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LUX-VALVE PLUS TRINITY STUDY RELEASED AT NEW YORK VALVES 2025 IN THE U.S.
- 2025.06.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
- 2025.05.23 VOLUNTARY ANNOUNCEMENTTHE FOLLOW-UP RESULTS OF LUX-VALVE PLUS TRINITY STUDYAND JENSCLIP CLINICAL STUDY PRESENTED AT EUROPCR 2025,SHOWING GOOD SAFETY AND PERFORMANCE
- 2025.05.22 POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON THURSDAY, MAY 22, 2025
- 2025.05.08 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
- 2025.04.22 NOTICE OF 2024 ANNUAL GENERAL MEETING
- 2025.04.22 PROXY FORM FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, MAY 22, 2025
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
